GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » uniQure NV (LTS:0EE0) » Definitions » Deferred Policy Acquisition Costs

uniQure NV (LTS:0EE0) Deferred Policy Acquisition Costs


View and export this data going back to 2018. Start your Free Trial

What is uniQure NV Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


uniQure NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » uniQure NV (LTS:0EE0) » Definitions » Deferred Policy Acquisition Costs
Traded in Other Exchanges
Address
Paasheuvelweg 25, Amsterdam, NH, NLD, 1105 BP
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.